VRTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $120,441,655.39

Vertex Pharmaceuticals Insider Trading History Chart

Vertex Pharmaceuticals Share Price & Price History

^$558.88

+0.30 (1.20%)

As of 10/30/2026 04:00 PM ET

Days: 30 | 90 | 365

Vertex Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/2/2026	Duncan McKechnie	EVP	Sell	1,541	$519.00	$799,779.00	11,001
7/2/2026	Ourania Tatsis	EVP	Sell	1,500	$524.99	$787,485.00	45,321
6/26/2026	Carmen Bozic	CMO	Sell	596	$482.50	$287,570.00	15,337
6/18/2026	Carmen Bozic	CMO	Sell	1,020	$462.17	$471,413.40	15,933
6/15/2026	Carmen Bozic	CMO	Sell	4,062	$450.00	$1,827,900.00	16,953
6/5/2026	Carmen Bozic	CMO	Sell	1,745	$450.00	$785,250.00	21,015
5/12/2026	Carmen Bozic	CMO	Sell	6,988	$450.00	$3,144,600.00	26,088
5/4/2026	Sangeeta N Bhatia	Director	Sell	318	$423.73	$134,746.14	4,924
5/1/2026	Joy Liu	EVP	Sell	1,104	$425.02	$469,222.08	20,729
4/1/2026	Joy Liu	EVP	Sell	978	$449.17	$439,288.26	21,833
3/13/2026	Carmen Bozic	CMO	Sell	2,329	$481.79	$1,122,088.91	35,405
2/25/2026	Amit Sachdev	EVP	Sell	1,846	$486.35	$897,802.10	55,570
2/25/2026	Duncan McKechnie	EVP	Sell	4,910	$487.65	$2,394,361.50	17,559
2/25/2026	E. Morrey Atkinson, III	EVP	Sell	668	$486.35	$324,881.80	18,432
2/25/2026	Jonathan Biller	EVP	Sell	945	$486.35	$459,600.75	13,659
2/25/2026	Kristen Ambrose	CAO	Sell	223	$486.35	$108,456.05	6,981
2/25/2026	Mark E. Bunnage	EVP	Sell	620	$486.35	$301,537.00	7,284
2/25/2026	Ourania Tatsis	EVP	Sell	260	$486.35	$126,451.00	46,763
2/19/2026	Amit Sachdev	EVP	Sell	58,613	$468.83	$27,479,532.79	58,934
2/13/2026	Ourania Tatsis	EVP	Sell	1,500	$499.99	$749,985.00	46,132
2/11/2026	E. Morrey Atkinson, III	EVP	Sell	1,751	$460.43	$806,212.93	22,046
2/11/2026	Jonathan Biller	EVP	Sell	1,925	$460.43	$886,327.75	20,819
2/11/2026	Kristen Ambrose	CAO	Sell	1,376	$460.43	$633,551.68	10,127
2/11/2026	Mark E. Bunnage	EVP	Sell	2,021	$460.43	$930,529.03	12,914
2/11/2026	Ourania Tatsis	EVP	Sell	466	$460.43	$214,560.38	51,436
1/7/2026	Ourania Tatsis	EVP	Sell	4,500	$474.99	$2,137,455.00	42,293
1/6/2026	Charles F. Wagner, Jr.	EVP	Sell	9,532	$461.00	$4,394,252.00	37,725
12/3/2025	Charles F. Wagner, Jr.	EVP	Sell	14,000	$456.00	$6,384,000.00	37,725
12/3/2025	Jeffrey M. Leiden	Chairman	Sell	63,781	$449.20	$28,650,425.20	24,026
11/14/2025	Jeffrey M. Leiden	Chairman	Sell	53,604	$440.72	$23,624,354.88	24,026
11/13/2025	Jeffrey M. Leiden	Chairman	Sell	19,688	$440.27	$8,668,035.76	24,026
8/6/2025	Bruce I. Sachs	Director	Buy	5,000	$389.68	$1,948,400.00	45,000
5/15/2025	David Altshuler	EVP	Sell	52	$424.69	$22,083.88	23,281
3/10/2025	David Altshuler	EVP	Sell	3,231	$500.00	$1,615,500.00	26,512
2/27/2025	Ourania Tatsis	EVP	Sell	530	$475.34	$251,930.20	58,539
2/18/2025	Ourania Tatsis	EVP	Sell	244	$455.06	$111,034.64	67,695
2/11/2025	Ourania Tatsis	EVP	Sell	310	$459.83	$142,547.30	64,021
11/15/2024	David Altshuler	EVP	Sell	15	$478.56	$7,178.40	25,813
8/30/2024	Jeffrey M. Leiden	Chairman	Sell	3,784	$499.00	$1,888,216.00	9,994
8/30/2024	Sangeeta N Bhatia	Director	Sell	646	$500.00	$323,000.00	4,435
8/7/2024	Carmen Bozic	CMO	Sell	2,280	$476.75	$1,086,990.00	23,259
8/1/2024	Bruce I. Sachs	Director	Sell	5,295	$508.00	$2,689,860.00	40,000
7/24/2024	Carmen Bozic	CMO	Sell	2,280	$488.46	$1,113,688.80	25,539
7/22/2024	Reshma Kewalramani	CEO	Sell	15,202	$497.00	$7,555,394.00	106,172
7/10/2024	Carmen Bozic	CMO	Sell	2,280	$487.34	$1,111,135.20	27,819
6/26/2024	Carmen Bozic	CMO	Sell	2,280	$471.72	$1,075,521.60	30,099
6/12/2024	Carmen Bozic	CMO	Sell	2,280	$478.00	$1,089,840.00	32,379
6/12/2024	E. Morrey Atkinson, III	EVP	Sell	7,288	$478.00	$3,483,664.00	15,972
5/30/2024	Ourania Tatsis	EVP	Sell	2,350	$439.11	$1,031,908.50	53,523
5/29/2024	Carmen Bozic	CMO	Sell	2,280	$445.56	$1,015,876.80	34,659
5/28/2024	Charles F. Wagner, Jr.	CFO	Sell	3,250	$454.79	$1,478,067.50	50,387
5/24/2024	Reshma Kewalramani	CEO	Sell	1,565	$457.00	$715,205.00	121,374
5/22/2024	Bruce I. Sachs	Director	Sell	7,073	$448.00	$3,168,704.00	40,000
2/26/2024	Ourania Tatsis	EVP	Sell	354	$425.70	$150,697.80	55,804
2/20/2024	Ourania Tatsis	EVP	Sell	480	$420.79	$201,979.20	59,827
2/12/2024	Amit Sachdev	EVP	Sell	3,222	$420.24	$1,354,013.28	74,364
2/12/2024	Jeffrey M. Leiden	Chairman	Sell	2,656	$419.51	$1,114,218.56	27,644
2/12/2024	Kristen Ambrose	CAO	Sell	1,374	$420.24	$577,409.76	9,676
2/12/2024	Stuart A. Arbuckle	COO	Sell	4,295	$420.24	$1,804,930.80	75,718
1/8/2024	Jeffrey M. Leiden	Chairman	Sell	6,648	$419.07	$2,785,977.36	2,423
11/6/2023	Bruce I. Sachs	Director	Sell	11,250	$385.00	$4,331,250.00	40,000

SEC Filings (Institutional Ownership Changes) for Vertex Pharmaceuticals (NASDAQ:VRTX)

90.96% of Vertex Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vertex Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/31/2026	Kestra Private Wealth Services LLC	10,659	$5.57M	0.1%	+1.1%	0.004%
10/31/2026	Boston Trust Walden Corp	439	$0.23M	0.0%	-9.5%	0.000%
10/31/2026	Northeast Investment Management	831	$0.43M	0.0%	-28.2%	0.000%
10/31/2026	Chicago Partners Investment Group LLC	2,578	$1.35M	0.0%	+5.0%	0.001%
10/31/2026	Covestor Ltd	341	$0.18M	0.1%	-7.3%	0.000%
10/31/2026	Richardson Financial Services Inc.	305	$0.16M	0.1%	+45.2%	0.000%
10/31/2026	Ascent Group LLC	3,936	$2.06M	0.1%	+6.3%	0.002%
10/31/2026	Kelleher Financial Advisors	100	$52K	0.0%	-31.5%	0.000%
10/30/2026	AIA Group Ltd	24,080	$12.59M	0.2%	-23.8%	0.009%
10/30/2026	Third View Private Wealth LLC	18,009	$9.42M	1.1%	+0.8%	0.007%
10/30/2026	Provenance Wealth Advisors LLC	2,018	$1.06M	0.1%	+20,080.0%	0.001%
10/30/2026	Associated Banc Corp	5,962	$3.12M	0.1%	N/A	0.002%
10/30/2026	Putney Financial Group LLC	468	$0.25M	0.2%	+6.1%	0.000%
10/30/2026	Integrity Alliance LLC.	575	$0.30M	0.0%	-21.4%	0.000%
10/30/2026	Factory Mutual Insurance Co.	4,587	$2.40M	0.0%	N/A	0.002%
10/30/2026	Aware Super Pty Ltd as trustee of Aware Super	20,055	$10.49M	0.1%	+121.9%	0.008%
10/30/2026	GraniteShares Advisors LLC	1,640	$0.86M	0.6%	-9.9%	0.001%
10/29/2026	Trek Financial LLC	686	$0.36M	0.0%	+6.2%	0.000%
10/29/2026	Traynor Capital Management Inc.	7,666	$4.01M	0.2%	-15.3%	0.003%
10/29/2026	Bank Julius Baer & Co. Ltd Zurich	303,964	$159.15M	0.4%	-4.8%	0.120%
10/29/2026	Greenleaf Trust	4,796	$2.51M	0.0%	-4.0%	0.002%
10/29/2026	Nippon Life Global Investors Americas Inc.	34,410	$17.99M	0.7%	-10.0%	0.014%
10/29/2026	Bell Investment Advisors Inc	260	$0.14M	0.0%	+73.3%	0.000%
10/29/2026	Sumitomo Mitsui Trust Group Inc.	594,358	$310.74M	0.2%	-2.9%	0.234%
10/29/2026	Mirae Asset Global Investments Co. Ltd.	223,081	$116.63M	0.2%	N/A	0.088%
10/29/2026	Profund Advisors LLC	23,062	$12.06M	0.4%	-1.4%	0.009%
10/29/2026	ProShare Advisors LLC	294,124	$153.77M	0.2%	+2.2%	0.116%
10/29/2026	Vise Technologies Inc.	9,344	$4.89M	0.0%	+18.5%	0.004%
10/29/2026	Grandfield & Dodd LLC	25,689	$13.43M	0.7%	+3.4%	0.010%
10/29/2026	Moss Adams Wealth Advisors LLC	961	$0.50M	0.0%	-8.7%	0.000%
10/29/2026	Global Assets Advisory LLC	2,145	$1.08M	0.2%	+5.7%	0.001%
10/29/2026	Summit Global Investments	9,982	$5.22M	0.3%	+39.0%	0.004%
10/29/2026	Invera Wealth Advisors LLC	871	$0.46M	0.2%	+5.3%	0.000%
10/29/2026	MGO One Seven LLC	2,469	$1.29M	0.0%	-31.1%	0.001%
10/29/2026	Americana Partners LLC	40,295	$21.07M	0.5%	+3.5%	0.016%
10/29/2026	Aprio Wealth Management LLC	647	$0.34M	0.0%	+7.8%	0.000%
10/29/2026	Avestar Capital LLC	1,992	$1.04M	0.1%	-31.3%	0.001%
10/29/2026	Modera Wealth Management LLC	19,815	$10.36M	0.1%	-1.1%	0.008%
10/29/2026	State of Wyoming	405	$0.21M	0.0%	+35.0%	0.000%
10/28/2026	Glenview Trust Co	6,773	$3.54M	0.0%	+0.3%	0.003%
10/28/2026	Parcion Private Wealth LLC	633	$0.33M	0.0%	+6.2%	0.000%
10/28/2026	Soltis Investment Advisors LLC	1,327	$0.69M	0.0%	+21.3%	0.001%
10/28/2026	Founders Financial Securities LLC	2,294	$1.20M	0.1%	-28.0%	0.001%
10/28/2026	United Asset Strategies Inc.	2,818	$1.47M	0.1%	-2.2%	0.001%
10/28/2026	Choreo LLC	5,932	$3.10M	0.0%	-8.4%	0.002%
10/28/2026	Interchange Capital Partners LLC	535	$0.28M	0.0%	+4.7%	0.000%
10/28/2026	China Universal Asset Management Co. Ltd.	51,810	$27.29M	1.4%	+7.3%	0.020%
10/28/2026	D.A. Davidson & CO.	4,570	$2.39M	0.0%	+0.5%	0.002%
10/28/2026	ICW Investment Advisors LLC	670	$0.35M	0.1%	-10.8%	0.000%
10/28/2026	Motley Fool Asset Management LLC	17,753	$9.28M	0.4%	+2.7%	0.007%
10/28/2026	Pinnacle Wealth Planning Services Inc.	1,066	$0.56M	0.1%	-19.3%	0.000%
10/28/2026	North Dakota State Investment Board	7,787	$4.07M	0.2%	+3.2%	0.003%
10/28/2026	VestGen Advisors LLC	4,870	$2.55M	0.1%	+121.5%	0.002%
10/28/2026	Simplify Asset Management Inc.	10,428	$5.45M	0.1%	-0.3%	0.004%
10/27/2026	Capital Wealth Management LLC	400	$0.21M	0.0%	N/A	0.000%
10/27/2026	Sigma Investment Counselors Inc.	9,806	$5.13M	0.2%	+7.9%	0.004%
10/27/2026	Victory Financial Group LLC	488	$0.26M	0.0%	N/A	0.000%
10/27/2026	Arrow Financial Corp	2,754	$1.44M	0.1%	-6.5%	0.001%
10/27/2026	Great Lakes Retirement Inc.	2,265	$1.18M	0.1%	+6.0%	0.001%
10/27/2026	Generali Asset Management SPA SGR	16,633	$8.70M	0.2%	+9.7%	0.007%
10/27/2026	Asset Management One Co. Ltd.	140,745	$73.58M	0.2%	+0.8%	0.055%
10/27/2026	MADDEN SECURITIES Corp	50	$26K	0.0%	N/A	0.000%
10/27/2026	Latitude Advisors LLC	151	$79K	0.0%	N/A	0.000%
10/27/2026	Roman Butler Fullerton & Co.	1,666	$0.84M	0.2%	+2.1%	0.001%
10/27/2026	SYM FINANCIAL Corp	543	$0.28M	0.0%	+17.5%	0.000%
10/27/2026	Oakworth Capital Inc.	154	$81K	0.0%	+24.2%	0.000%
10/27/2026	Independence Bank of Kentucky	4,474	$2.34M	0.3%	-0.7%	0.002%
10/27/2026	Angeles Wealth Management LLC	1,658	$0.87M	0.0%	+17.7%	0.001%
10/27/2026	Ashton Thomas Securities LLC	3,130	$1.64M	0.2%	+1.3%	0.001%
10/27/2026	Total Clarity Wealth Management Inc.	1,750	$0.92M	0.2%	+7.3%	0.001%
10/27/2026	Schwartz Investment Counsel Inc.	700	$0.37M	0.0%	-30.0%	0.000%
10/26/2026	Abundance Wealth Counselors	856	$0.45M	0.1%	+19.4%	0.000%
10/26/2026	Oppenheimer & Co. Inc.	4,581	$2.40M	0.0%	+7.8%	0.002%
10/26/2026	Park Avenue Securities LLC	10,308	$5.39M	0.0%	+1.1%	0.004%
10/26/2026	Verdence Capital Advisors LLC	1,946	$1.02M	0.0%	+2.4%	0.001%
10/26/2026	AGH Wealth Advisors LLC	877	$0.46M	0.3%	-16.9%	0.000%
10/24/2026	Apollon Wealth Management LLC	56,933	$29.77M	0.3%	-10.9%	0.022%
10/24/2026	Slow Capital Inc.	13,170	$6.89M	0.8%	-0.8%	0.005%
10/24/2026	Hedeker Wealth LLC	9,264	$4.84M	0.9%	+23.3%	0.004%
10/24/2026	Kingswood Wealth Advisors LLC	1,597	$0.84M	0.0%	+14.6%	0.001%
10/24/2026	Sigma Planning Corp	3,609	$1.88M	0.0%	+249.4%	0.001%
10/24/2026	Revolve Wealth Partners LLC	395	$0.21M	0.0%	N/A	0.000%
10/24/2026	Provident Investment Management Inc.	131,577	$68.79M	6.9%	-6.5%	0.052%
10/23/2026	MN Wealth Advisors LLC	3,129	$1.64M	0.7%	+1.0%	0.001%
10/23/2026	Signaturefd LLC	5,773	$3.02M	0.0%	+3.2%	0.002%
10/23/2026	BG Investment Services LLC	2,046	$1.07M	0.2%	N/A	0.001%
10/23/2026	McGuire Investment Group LLC	4,174	$2.18M	0.2%	+2.2%	0.002%
10/23/2026	Citizens Financial Group Inc. RI	49,270	$25.76M	0.3%	-3.4%	0.019%
10/23/2026	Simplicity Wealth LLC	2,916	$1.53M	0.0%	+4.4%	0.001%
10/23/2026	Sowell Financial Services LLC	2,707	$1.42M	0.0%	-7.6%	0.001%
10/23/2026	One Wealth Capital Management LLC	443	$0.23M	0.1%	-88.7%	0.000%
10/23/2026	Evergreen Capital Management LLC	4,257	$2.23M	0.0%	+0.8%	0.002%
10/23/2026	Gibbs Wealth Management	6,074	$3.18M	0.3%	+10.8%	0.002%
10/23/2026	Lantern Wealth Advisors LLC	1,350	$0.71M	0.3%	+8.0%	0.001%
10/23/2026	Manchester Capital Management LLC	222	$0.12M	0.0%	-43.2%	0.000%
10/23/2026	Lighthouse Financial LLC	9,910	$5.18M	2.3%	+52.1%	0.004%
10/23/2026	Fifth Third Wealth Advisors LLC	1,911	$1M	0.0%	+3.4%	0.001%
10/23/2026	Sterling Capital Management LLC	7,535	$3.94M	0.1%	-12.9%	0.003%
10/23/2026	WASHINGTON TRUST Co	517	$0.27M	0.0%	-3.7%	0.000%
10/23/2026	XXI Wealth LLC	502	$0.26M	0.1%	+6.4%	0.000%

Data available starting January 2016

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/SYMKEVI for people with CF for 6 years of age or older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 year or older who have CF with ivacaftor. The company's pipeline includes VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1 clinical trial; VX-548, a non-opioid medicine for the treatment of acute and neuropathic pain which is in Phase 3 clinical trial; Exa-cel, for the treatment of sickle cell disease and transfusion-dependent beta thalassemia which is in Phase 2/3 clinical trial. In addition, it provides inaxaplin for the treatment of APOL1-mediated focal segmental glomerulosclerosis and co-morbidities, such as hypertension which is in single Phase 2/3; VX- 880 and VX-264, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-970, which is in Phase 2 clinical trial for the treatment of cancer; and VX-803 and VX-984 for treatment of cancer in Phase 1 clinical trial. Further, it sells the products to specialty pharmacy and specialty distributors in the United States, as well as retail pharmacies, hospitals, and clinics. Additionally, the company has collaborations with CRISPR Therapeutics AG.; Moderna, Inc.; Entrada Therapeutics, Inc.; Arbor Biotechnologies, Inc.; Mammoth Biosciences, Inc.; and Verve Therapeutics., as well as collaborations with Tevard Biosciences to develop novel tRNA-based therapies for duchenne muscular dystrophy. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $558.88

$549.89

$563.80

50 Day Range

MA: $523.21

$485.22

$558.88

52 Week Range

Now: $558.88

$403.16

$563.80

Volume

3,029,665 shs

Average Volume

1,394,524 shs

Market Capitalization

$141.84 billion

P/E Ratio

32.53

Dividend Yield

N/A

Beta

0.28

Who are the company insiders with the largest holdings of Vertex Pharmaceuticals?: Vertex Pharmaceuticals' top insider shareholders include:
Jeffrey M Leiden (CEO)
Joshua S Boger (Director)
Joshua Boger (Director)
Joshua S Boger (Director)
Jeffrey M Leiden (CEO)
Jeffrey Leiden (CEO)
Peter Mueller (EVP)
Ian F Smith (CFO)
Stuart A Arbuckle (EVP)
Jeffrey Chodakewitz (CMO)
Learn More about top insider investors at Vertex Pharmaceuticals.
Who are the major institutional investors of Vertex Pharmaceuticals?: Vertex Pharmaceuticals' top institutional investors include:
Sumitomo Mitsui Trust Group Inc. — 0.23%
Robeco Institutional Asset Management B.V. — 0.17%
AMF Tjanstepension AB — 0.15%
Bank Julius Baer & Co. Ltd Zurich — 0.12%
ProShare Advisors LLC — 0.12%
Mirae Asset Global Investments Co. Ltd. — 0.09%
Learn More about top institutional investors of Vertex Pharmaceuticals stock.
Which major investors are selling Vertex Pharmaceuticals stock?: Within the previous quarter, VRTX stock was sold by these institutional investors:
Sumitomo Mitsui Trust Group Inc.
Bank Julius Baer & Co. Ltd Zurich
Provident Investment Management Inc.
AIA Group Ltd
Apollon Wealth Management LLC
Sumitomo Mitsui DS Asset Management Company Ltd
Nippon Life Global Investors Americas Inc.
Banque Pictet & Cie SA
In the last year, company insiders that have sold Vertex Pharmaceuticals company stock include:
Amit Sachdev (EVP)
Ourania Tatsis (EVP)
Charles F Wagner Jr (EVP)
Carmen Bozic (CMO)
Jeffrey M Leiden (Chairman)
Edward Morrow Atkinson III (EVP)
Joy Liu (EVP)
Jonathan Biller (EVP)
Duncan Mckechnie (EVP)
Mark E Bunnage (EVP)
Kristen Ambrose (CAO)
Sangeeta N Bhatia (Director)
Learn More investors selling Vertex Pharmaceuticals stock.
Which major investors are buying Vertex Pharmaceuticals stock?: During the previous quarter, VRTX stock was acquired by institutional investors including:
Mirae Asset Global Investments Co. Ltd.
AMF Tjanstepension AB
AMI Asset Management Corp
E. Ohman J or Asset Management AB
Robeco Institutional Asset Management B.V.
Aware Super Pty Ltd as trustee of Aware Super
ProShare Advisors LLC
Associated Banc Corp